(Q43566439)

24 November 2017

Association between metformin use and risk of prostate cancer and its grade (English)

1 reference

24 November 2017

1 reference

1 reference

4

1 reference

24 November 2017

6

1 reference

24 November 2017

3

Lorraine L Lipscombe

1 reference

24 November 2017

1

David Margel

1 reference

24 November 2017

2

David Urbach

1 reference

24 November 2017

5

Girish Kulkarni

1 reference

24 November 2017

7

Neil Fleshner

1 reference

PubMed ID

23853056

24 November 2017

language of work or name

English

0 references

publication date

13 July 2013

1 reference

Journal of the National Cancer Institute

24 November 2017

1 reference

24 November 2017

105

1 reference

24 November 2017

15

1 reference

24 November 2017

1123-1131

1 reference

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

24 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

International variation in prostate cancer incidence and mortality rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Metformin and other biguanides in oncology: advancing the research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Targeting AMPK: a new therapeutic opportunity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Effect of dutasteride on the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Longer wait times increase overall mortality in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Diabetes mellitus and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Maturation of autophagic vacuoles in Mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Self-eating and self-killing: crosstalk between autophagy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

Prostate cancer and the Will Rogers phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT170

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJT170

1 reference

24 November 2017

1 reference

PubMed ID

23853056